메뉴 건너뛰기
PharmacoEconomics
Volumn 24, Issue 12, 2006, Pages 1273-1274
Discounting health effects in pharmacoeconomic evaluations: Current controversies [1]
Author keywords

[No Author keywords available]
Indexed keywords

CAR; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; HEALTH CARE; LETTER; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL;
EID: 33845450721     PISSN: 11707690     EISSN: 11707690     Source Type: Journal    
DOI: 10.2165/00019053-200624120-00009     Document Type: Letter
Times cited : (3)
References (3)
  • 1
    • 22344458113 scopus 로고    scopus 로고
    • Discounting health effects in pharmacoeconomic evaluations: Current controversies
    • Bos JM, Postma MJ, Annemans L. Discounting health effects in pharmacoeconomic evaluations: current controversies. Pharmacoeconomics 2005; 23 (7): 639-49
    • (2005) Pharmacoeconomics , vol.23 , Issue.7 , pp. 639-649
    • Bos, J.M.1    Postma, M.J.2    Annemans, L.3
  • 2
    • 29244475375 scopus 로고    scopus 로고
    • Severity of illness and priority setting: Worrisome lack of discussion of surprising finding
    • Nord E. Severity of illness and priority setting: worrisome lack of discussion of surprising finding. J Health Econ 2006; 25 (1): 170-2
    • (2006) J Health Econ , vol.25 , Issue.1 , pp. 170-172
    • Nord, E.1
  • 3
    • 32644439825 scopus 로고    scopus 로고
    • Should patients have a greater role in valuing health states?
    • Brazier J, Akehurst R, Brennan A, et al. Should patients have a greater role in valuing health states? Appl Health Econ Health Policy 2005; 4 (4): 201-8
    • (2005) Appl Health Econ Health Policy , vol.4 , Issue.4 , pp. 201-208
    • Brazier, J.1    Akehurst, R.2    Brennan, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.